Despite its effectiveness, Xtandi is not a cure for prostate cancer. It is primarily used to manage the disease and improve quality of life. Some patients may not respond to the treatment, and resistance to the drug can develop over time. Additionally, the cost of Xtandi can be high, which may limit accessibility for some patients.